Mirum Pharmaceuticals, Inc. (MIRM) › Shareholders' EquityMirum Pharmaceuticals, Inc. (MIRM) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$17.31M2019: $130.35M2020: $172.09M2021: $120.21M2022: $142.04M2023: $248.67M2024: $225.64M2025: $314.69M$314.69M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$314.69M+39.5%2024$225.64M-9.3%2023$248.67M+75.1%2022$142.04M+18.2%2021$120.21M-30.1%2020$172.09M+32.0%2019$130.35M+852.9%2018-$17.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share